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1. Introduction
   Invasive fungal infections caused by Candida spp. 
remain a major cause of morbidity and mortality in 
the immunocompromised individuals, and more than 
150 species of yeast have now been associated with 
human pathologies[1-3]. Although Candida albicans (C. 
albicans) remained the predominant agent of nosocomial 
infections, an increasing number of infections are 
being attributed to non-albicans species, such as 
Candida glabrata (C. glabrata), Candida parapsilosis 
(C. parapsilosis), Candida tropicalis (C. tropicalis), 
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Objective: To identify Candida species in asymptomatic subjects in Bobo-Dioulasso (Burkina 
Faso) by the matrix-assisted laser desorption ionization-time of flight mass spectrometry. 
Methods: A cross-sectional study was conducted from January to February 2013 in Bobo-
Dioulasso to collect fecal and urine specimens from voluntary donors. Fungal strains were isolated 
on Sabouraud dextrose agar and analyzed using matrix-assisted laser desorption ionisation-
time-of-flight mass spectrometry. 
Results: A total of 135 samples including stools (78.5%, 106/135) and urine (21.5%, 29/135) were 
analyzed. The results revealed that fecal specimens contained mainly Candida krusei (C. krusei) 
(42.5%) followed by Candida albicans (29.3%), Candida glabrata (18.0%) and Candida tropicalis 
(C. tropicalis) (4.7%). C. krusei (34.6%) was also found to be the most frequently identified in urine 
samples followed by Candida albicans (27.0%), C. tropicalis (15.4%) and Candida parapsilosis. 
However, uncommon species such as Candida nivariensis, Candida kefyr, Candida norvegensis, 
Candida parapsilosis, Candida lusitaniae and Candida robusta were also identified from fecal 
and urines samples. 
Conclusions: This study noted the emergence of species such as C. krusei, Candida glabrata, 
Candida parapsiolosis, C. tropicalis, Candida nivariensis, Candida norvegensis, and others. It is 
an imperative to take into account the existence of these species in the therapeutic management 
of patients in Bobo-Dioulasso.
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Candida lusitaniae, and Candida krusei (C. krusei) that 
emerged over recent years as significant opportunistic 
pathogens[4,5]. 
   Recent studies concerning the epidemiology of invasive 
mycoses showed a significant change in the profile of 
Candida species involved in human pathology[2]. Many 
strains of C. albicans are still susceptible to antifungals; 
however species such as C. krusei, C. glabrata, Candida 
bracarensis, Candida nivariensis (C. nivariensis), C. 
parapsilosis and Candida guilliermondii have developed 
intrinsic resistance to triazoles, amphotericin B or to 
echinocandins[6,7]. It is therefore essential to consider 
these changes in fungal ecology upon the therapeutic 
management of patients, particularly for empirical 
prescription.
   Given the inherently variable antifungal susceptibility 
profiles of Candida spp., the correct identification of 
the species is often critical for efficient therapeutic 
decisions. The identification of the species therefore 
remains a crucial element in prediction of the response to 
antifungal treatment[8]. The main Candida spp. associated 
with human disease are readily identified by conventional 
mycological methods, which rely upon a combination of 
morphological features coupled with the abilities of the 
organisms to metabolize selected sugars or assimilate a 
variety of carbon and nitrogen sources. This requires two 
to five days or more in the case of uncommon species[9]. 
These phenotypic methods can sometimes lead to 
misidentification or imprecise identification, especially 
for species phylogenetically proximate, such as C. 
albicans/Candida dubliniensis, Candida inconspicua/
Candida norvegensis (C. norvegensis) or C. glabrata/
C. nivariensis/Candida bracarensis [9,10].  Thus, the 
adequate identification of these species often requires 
the combination of several phenotypic and molecular 
approaches to increase the discrimination level. The 
molecular approaches are based on the analysis of 
the genes encoding the ribosomal RNA. More recently, 
molecular methods, including restriction fragment length 
polymorphism, sequencing of internal transcribed spacer 
regions, multilocus sequence typing, and barcoding have 
been used to identify clinical and nonclinical isolates. 
All these methods are relatively expensive and time-
consuming[11,12]. Recent studies report the use of mass 
spectroscopy for the identification of yeasts as a serious 
alternative for conventional identification methods[13,14].
   Burkina Faso is a sub Saharan country, with endemic 
HIV infection and fungal infections. Despite this, there is 
no coordination on the question of HIV and opportunistic 
mycoses. In the country, even though the data exist on the 
identification and management of therapeutics bacteria, 
there is limited data on fungal infections. The present 
study was conducted in Bobo-Dioulasso, a town located 
in the south-western of Burkina Faso. The main objective 
was to identify Candida species by matrix-assisted laser 
desorption ionization-time of flight (MALDI-TOF) mass 
spectrometry (MS) in asymptomatic individuals. 
2. Materials and methods
2.1. Yeast collection strains
   A cross-sectional study was conducted to collect fecal 
and urine samples from voluntary donors for a total period 
of two months in the laboratory of Parasitology-Mycology 
in the university hospital of Bobo-Dioulasso. The collected 
samples included urines and stool. Fungal strains were 
isolated from these samples by cultivation on Sabouraud 
dextrose agar and frozen in sterile water at -20 °C until 
used[9].
2.2. Sample preparation 
   Pure fungal strains from frozen stocks were obtained 
by 24 to 48 h incubation on BBL-CHROME agar™ or 
CandiSelect4™ or on Sabouraud medium supplemented with 
antibiotics[15,16]. For the MALDI-TOF assay, the on-target 
extraction method was used. In brief, microorganisms from 
a colony were applied directly to a disposable target slide 
using 1 µL loop[15,17]. They were lysed with 1.2 µL of 70% 
formic acid and dried at room temperature. Subsequently, 
each sample was overlaid with 1.2 µL of matrix solution, 
a saturated solution of α-cyano-4-hydroxycinnamic acid 
(CHCA), and air dried at room temperature. 
   The CHCA matrix co crystallized with the sample and dried 
on a metal plate (96-AnchorChip™ spot or spots Polished 
Steel™ 384, Bruker Daltonics) on the site of a spot. The 
reading of the plate was made in 24 h by MALDI-TOF system 
(Bruker Daltonics GmbH, Bremen, Germany).
3. Results
   A total of 135 fecal samples (78.5%, 106/135) and urine 
(21.5%, 29/135) from voluntary donors were analyzed by the 
MALDI-TOF assay. Candida was the only genus of yeast 
identified by the MALDI-TOF. A total of 132 samples (97.8%, 
132/135) were successfully identified through direct deposit 
on the target. Three urine samples (2.2%, 3/135) were neither 
identified after direct deposit nor after complete extraction 
of proteins. Thus success rate of species identification in 
MALDI-TOF was 97.8% (132/135).
   From 106 species identified from fecal samples, C. krusei 
(42.5%) was the most frequent followed by C. albicans 
(29.3%), C. glabrata (18.0%) and C. tropicalis (4.7%) (Figure 1). 
Uncommon species such as C. nivariensis, Candida kefyr, C. 
norvegensis, C. parapsilosis, and Candida robusta were also 
identified.
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Figure 1. Candida species identified in stools by MALDI-TOF assay.
Ckr: C. krusei, Cal: C. albicans, Cgl: C. glabrata, Ctr: C. tropicalis, Cni: C. nivariensis, 
Cke: Candida kefyr, Cno: C. norvegensis, Cpa: C. parapsilosis, Cro: Candida robusta.
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For urine, a total of 26 samples were successfully analyzed 
by MALDI-TOF system. C. krusei (34.6%) was the most frequent 
followed by C. albicans (27%), C. tropicalis (15.4%), and C. 
parapsilosis (Figure 2). C. glabrata, Candida lusitaniae and 
Candida robusta were the uncommon species identified 
from urines.
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Figure 2. Candida species identified in urine by MALDI-TOF assay.
Ckr: C. krusei, Cal: C. albicans, Ctr: C. tropicalis, Cpa: C. parapsilosis, Cgl: C. glabrata, 
Clu: Candida lusitaniae, Cro: Candida robusta.
4. Discussion
   The recent evolution of epidemiology of invasive fungal 
infections is marked by a spectacular increase in non-
albicans species. Diversity of non-albicans species 
prompted biologists to develop new tools for molecular and 
immunological characterization of some unusual species 
whose identification by phenotype methods has proven 
difficult. More recently, MALDI-TOF MS has been proposed 
as alternative conventional methods[18]. The present study 
was designed as identifying some Candida species isolated 
from stool and urine samples in Bobo-Dioulasso by using 
MALDI-TOF system. According to our results, C. krusei 
prevailed in fecal samples and urine samples. Usually, 
this species is non-pathogenic in the absence of subjacent 
immunosuppression; this justifies this high prevalence 
in asymptomatic voluntary donors. In contrast, previous 
studies showed the predominance of C. albicans in 50% of 
pathological samples beside the other species emerging 
such as C. krusei, C. glabrata, C. parapsiolosis, C. tropicalis, 
C. nivariensis, C. norvegensis, and others[2,4].
   Candida albicans and most of non-albicans yeasts 
identified in this study such as C. krusei, C. glabrata, C. 
parapsiolosis, C. tropicalis, C. nivariensis, C. norvegensis 
are the saprophytes of the digestive tract of humans and 
many animals. These yeasts are opportunistic which 
become pathogenic under the influence of general risk 
factors notably, imbalance of intestinal flora after taking 
antibiotics or local risk factors including diabetes and 
deficit of immunity. Identification of these yeasts in this 
study corroborates their emerging nature in human fungal 
infections. However, the emergence requires a correct 
phenotypic and molecular identification for adequate 
therapeutic management of patients. In our context, further 
large-scale study in all health regions of Burkina Faso 
taking into account pathological samples would allow better 
understanding of their epidemiology.
   Furthermore, the identification of some species such 
as C. nivariensis, C. glabrata, C. parapsilosis which 
showed intrinsic resistance to usual antifungal should be 
investigated for antifungal susceptibility[19]. In fact, these 
strains are from Bobo-Dioulasso, where the prescription 
of antifungals is almost inexistent compared to antibiotics 
which are widely prescribed against any infectious. This low 
usage of antifungals could give another behavior of isolates 
from Bobo-Dioulasso for the use of antifungal agents. The 
investigation for antifungal susceptibility would permit a 
better understanding of the susceptibility of these isolates 
which showed intrinsic resistance to conventional antifungal 
such as triazole and amphotericin[19]. 
   Moreover, three strains (2.2%) from this study could not 
be identified by MALDI-TOF system. In fact, uncommon 
yeast species are emerging as human pathogens and their 
identification may pose a challenge when the type strains 
have not yet been included into the diagnostic databases of 
identification system. This can lead to misidentification of 
species. In addition, it is essential that databases designers 
provide regular updates. This update is major advantage for 
identification by MALDI-TOF. In fact, two common causes of 
identification failures may be related to the content of the 
database[20].
   Mass spectrometry MALDI-TOF allows rapid identification 
of microorganisms isolated in a routine laboratory. The 
present study is the first conducted in Bobo-Dioulasso. Some 
emerging species of Candida such as C. krusei, C. glabrata, 
C. parapsiolosis, C. tropicalis, C. nivariensis, C. norvegensis, 
have been recorded. These species being isolated from 
asymptomatic subjects could become pathogenic at any 
time; it is imperative to take into account the existence of 
these species in the therapeutic management of patients 
in Bobo-Dioulasso. However, further large-scale study 
in all health regions of Burkina Faso taking into account 
pathological samples would allow better understanding 
of the epidemiology of Candida yeasts and establish the 
cartography of these species.
Conflict of interest statement
   We declare that we have no conflict of interest.
Acknowledgements
   Authors thank all the patients who participated in the 
study and all staff of Laboratory of Parasitology-Mycology, 
CHU Saint Antoine (Paris). 
Comments 
Background
   Invasive infections by Candida spp. are one of the major 
threads particularly for immuno-compromised patients. 
In candidiasis, Candida albicans has long been a major 
pathogen, but clinical reports of infections of other Candida 
species are rapidly increasing in late years. Because 
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different Candida species show different antifungal drug 
susceptibility, accurate and succinct methods for species 
identification are required.
  
Research frontiers
   The authors determined Candida species cultured from 
fecal and urine specimens corrected from asymptomatic 
subjects in a town of Burkina Faso, using MALDI-TOF method.
Related reports
   Recent studies report the use of mass spectroscopy for 
the identification of yeasts as a serious alternative for 
conventional identification methods.
 
Innovations and breakthroughs
   Candida krusei and some other Candida species which 
are not usual main human pathogens are found in fecal 
and urine samples from asymptomatic voluntary donors. 
The authors are warning and insisting that establishment of 
proper and simple method for identifying Candida species 
are required, because susceptibility of antibiotics is different 
among Candida species. 
  
Applications
   Diagnosis, epidemiology, and preventive measures are 
applied against candidiasis. The identification of some 
species such as C. nivariensis, C. glabrata, C. parapsilosis 
which showed intrinsic resistance to usual antifungal should 
be investigated for antifungal susceptibility.   
Peer review
   The paper describes several Candida species and 
their percentages found in fecal and urine samples of 
asymptomatic voluntary donors in a town of Burkina Faso. 
The authors used MALDI-TOF MS method which is supposed 
to be one of the most accurate and succinct methods for 
identification of fungi and other microorganisms. Although 
the present work is performed on asymptomatic donors, 
the work would help in future diagnosis of patients with 
candidiasis.
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